March 10, 2026

Beam Therapeutics Inc. (BEAM): Investor Outlook on a Biotech with 80% Upside Potential

Beam Therapeutics Inc. (NASDAQ: BEAM) stands out in the biotechnology sector with its robust pipeline of precision genetic medicines, targeting serious diseases through innovative therapies. Founded..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking the 175% Potential Upside

Investors are taking a keen interest in Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, as it continues to make waves in the biotechnology sector...

Privia Health Group, Inc. (PRVA): Analyst Consensus Highlights 36.7% Upside Potential

For investors keen on tapping into the healthcare sector’s burgeoning technology and services segment, Privia Health Group, Inc. (NASDAQ: PRVA) presents a compelling opportunity. The company’s..

CG Oncology, Inc. (CGON) Stock Analysis: Unpacking a 31% Potential Upside in Biotech’s Hot Sector

As CG Oncology, Inc. (CGON) continues to make waves in the healthcare sector, particularly within the biotechnology industry, investors are taking a keen interest in its..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Evaluating a 28% Upside Potential in Biotech

PTC Therapeutics, Inc. (NASDAQ: PTCT) is making waves in the biotechnology sector, offering investors an intriguing opportunity given its current market positioning and growth prospects. With..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 12.76% Potential Upside in the Healthcare Sector

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector with a market capitalization of $2.56 billion, operates at the intersection of medical instruments..

Veracyte, Inc. (VCYT): Investor Outlook Highlights 42% Potential Upside

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector specializing in diagnostics and research, is currently capturing the attention of investors thanks to a..

Progyny, Inc. (PGNY) Investor Outlook: Exploring a 56.91% Potential Upside in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) stands out in the healthcare sector as a prominent player in the niche market of fertility and family-building benefits. For investors seeking..

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 68.77% Upside Potential in Biotechnology

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) stands at the forefront of the biotechnology sector, with a market capitalization of $2.56 billion. Headquartered in Waltham, Massachusetts, this commercial-stage..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 50.93% Upside Potential in the Medical Device Sector

UFP Technologies, Inc. (UFPT), a key player in the medical device sector, is drawing significant attention from investors due to its robust market positioning and impressive..

Sotera Health Company (SHC) Stock Analysis: A 42% Potential Upside Beckons Investors

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Ardent Health, Inc. (ARDT) Stock Analysis: Navigating a 39.77% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (ARDT) is garnering attention within the healthcare sector for its potential upside of nearly 40%, according to recent analyst ratings. Operating in the..

Alvotech (ALVO) Stock Analysis: Is a 368% Upside Within Reach for This Biosimilar Pioneer?

Alvotech (NASDAQ: ALVO) is steadily carving out its niche in the healthcare sector, focusing on the development and manufacturing of biosimilar medicines. With a market capitalization..

Scholar Rock Holding Corporation (SRRK): Investor Outlook on a Biotech Innovator with 24.51% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is increasingly becoming a focal point for investors looking to capitalize on the innovative strides being made in the biotechnology..

Immunovant, Inc. (IMVT) Stock Analysis: Potential 55% Upside Sparks Investor Interest

Immunovant, Inc. (NASDAQ: IMVT), a promising player in the biotechnology sector, has captured investor attention with its potential for significant upside. With a market capitalization of..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Gem with 18% Potential Upside

Belite Bio, Inc (NASDAQ: BLTE) stands as a promising prospect in the biotechnology sector, captivating investor interest with its robust clinical pipeline and a potential upside..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 62% Upside Potential in the Biotechnology Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology sector, is capturing investor attention with its promising growth prospects and robust market position. With a..

LivaNova PLC (LIVN): Investor Outlook on Strong Revenue Growth Amidst Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, particularly within the medical devices industry, presents a compelling case for investors seeking exposure to..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 30% Potential Upside in Biotechnology

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology firm based in Zug, Switzerland, is making waves in the healthcare sector. Specializing in innovative treatments for inflammatory skin..

GeneDx Holdings Corp. (WGS) Stock Analysis: A Healthcare Genomics Leader with 65.77% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS) is capturing investor attention across the healthcare sector with its robust position in the diagnostics and research industry. With a market..

Search

Funds

March 10, 2026

Search

Funds

March 10, 2026

FTSE 100

Funds